> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# TrialSpark
- URL: https://www.whiteroseintelligence.com/trialspark/
- Published: 1999-01-03T01:40:00.000Z
- Updated: 2025-01-04T02:44:42.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**TrialSpark** is an American clinical trials company based in New York.

## History

On November 29, 2022, TrialSpark announced the formation of Libertas Bio after it had acquired a majority position in a portfolio of immunodermatology assets from Asana BioSciences.[\[1\]](#fn1)

## Investors

Investors in TrialSpark include:[\[2\]](#fn2)[\[3\]](#fn3)[\[4\]](#fn4)[\[5\]](#fn5)

- Anne Wojcicki
- ArrowMark Partners
- Casdin Capital
- Dragoneer Investment Group
- Felicis
- John Doerr
- Lachy Groom
- [Sam Altman](https://www.whiteroseintelligence.com/Sam-Altman)
- [Section 32](https://www.whiteroseintelligence.com/Section-32)
- Sequoia Capital
- Sound Ventures
- Spark Capital
- [Thrive Capital](https://www.whiteroseintelligence.com/Thrive-Capital)
- TQ Ventures

## External links

- [Crunchbase](https://www.crunchbase.com/organization/trialspark)
- [LinkedIn](https://www.linkedin.com/company/trialspark/)
- [Website](https://www.trialspark.com/)

---

1. *TrialSpark announces acquisition of a clinical-stage immunodermatology portfolio and formation of Libertas Bio.* (2022, November 29). BioSpace. <https://web.archive.org/web/20230728172436/https://www.biospace.com/article/releases/trialspark-announces-acquisition-of-a-clinical-stage-immunodermatology-portfolio-and-formation-of-libertas-bio/> [↩︎](#fnref1)
2. *TrialSpark - Funding, Financials, Valuation & Investors.* Crunchbase. Retrieved July 28, 2023, from <https://www.crunchbase.com/organization/trialspark/company%5Ffinancials> [↩︎](#fnref2)
3. *Venture Round - TrialSpark - 2018-10-15 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved July 28, 2023, from <https://www.crunchbase.com/funding%5Fround/trialspark-series-unknown--abcf16de> [↩︎](#fnref3)
4. *Series C - TrialSpark - 2021-09-30 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved July 28, 2023, from <https://www.crunchbase.com/funding%5Fround/trialspark-series-c--bcfe174f> [↩︎](#fnref4)
5. Bloomberg. (2021, September 30). *Startup with $120 million for deals aims to make drugs cheaply.* Mint. <http://archive.today/2023.07.28-234253/https://www.livemint.com/companies/start-ups/trialspark-with-120-million-for-deals-aims-to-make-drugs-cheaply-11633008141507.html> [↩︎](#fnref5)